The problem
The Global Fund is the established mechanism for procuring essential medicines for infectious diseases, with a special focus on HIV, tuberculosis and malaria. Without sustained financial support, people may not be able to access critical medicines when they need them.
Download the project evaluation
Our response
This project aimed to scale up access to treatment and reduce prices of medicines for the treatment of HIV/AIDS, multidrug-resistant tuberculosis (MDR-TB) and malaria through Global Fund grants in round 6, phase 1. The grants enabled the procurement of antiretroviral drugs for HIV, artemisinin-based combination therapies for malaria, and treatments for MDR-TB across more than 30 countries.
